Population-level and longitudinal MIC distributions for antimicrobials against drug-resistant <i>Mycobacterium tuberculosis</i> in Wuxi, a low-epidemic city in China, from 2019 to 2023.

Front Cell Infect Microbiol · 2026 · PMC13388225 · PMID 42488414

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

From 2019 to 2023, among the DR-TB cohorts, the MICs of isoniazid, ethionamide, para-aminosalicylic acid, and amikacin showed an increasing trend, whereas ethambutol exhibited a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Population-level and longitudinal MIC distributions for antimicrobials against drug-resistant &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; in Wuxi, a low-epidemic city in China, from 2019 to 2023.

The sentences

Population-level and longitudinal MIC distributions for antimicrobials against drug-resistant <i>Mycobacterium tuberculosis</i> in Wuxi, a low-epidemic city in China, from 2019 to 2023.